Melissa Jöe

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Blood Brain Barrier

Pluripotent Stem Cells

Subarachnoid Hemorrhage

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)
James R Tribble, Melissa Jöe, Carmine Varricchio, Amin Otmani, Alessio Canovai, Baninia Habchi, Evangelia Daskalakis, Romanas Chaleckis, Andrea Loreto, Jonathan Gilley, Craig E Wheelock, Gauti Jóhannesson, Raymond Ching-Bong Wong, Michael P Coleman, Andrea Brancale, Pete A Williams
NMNAT2 is a druggable target to drive neuronal NAD production. Nature communications 15 (1) (2024)